Among these alterations, the 2016 CNS WHO classification regards the IDH mutation and the 1p19q co-deletion as essential markers for a molecular diagnosis of diffuse glioma, and the H3 K27M mutation as an essential marker of pediatric glioma [1]. Here, IDH1 is linked to glioma.